Pontin调控TβRII基因转录及可变剪接活化TGF-β信号通路在胶质瘤侵袭中的机理研究
批准号:
81972354
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
周雪霞
依托单位:
学科分类:
肿瘤复发与转移
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
周雪霞
中文摘要
高度侵袭是导致恶性胶质瘤不易全切、术后易复发的重要原因,由TβRII受体介导的TGF-β信号通路活化是胶质瘤侵袭的研究热点。我们前期发现:(1)ATP酶Pontin在胶质瘤中表达异常升高,且与较差的预后相关;(2)细胞学实验证实Pontin的核定位特点和促侵袭作用;(3)RNA-seq初步分析发现,Pontin敲低后引起TGF-β信号通路抑制、TβRII基因转录及可变剪接失调。据此,我们提出科学假说,Pontin参与TβRII基因转录及可变剪接调控、活化TGF-β信号通路是胶质瘤获得高侵袭性的新机制。本研究拟采用多种分子、细胞、动物实验手段,深入探讨Pontin在胶质瘤侵袭及其他相关恶性生物学行为中的作用,剖析Pontin促进TβRII基因转录及可变剪接的调控机制,以期鉴定胶质瘤中全新的促癌因子Pontin,揭示胶质瘤侵袭新机制,最终为胶质瘤治疗提供可能的新方法和新靶点。
英文摘要
For the malignant glioma, the highly invasive potential principally makes complete tumor resection impossible and easy recurrence after surgery. As the receptor that TGF-β directly binds, TβRII serves as a gatekeeper for TGF-β signaling activation, which is a hotspot of glioma invasion investigation. Our previous results showed that, (1) Pontin, the human ATPase of the AAA+ (ATPases associated with diverse cellular activities) superfamily, was abnormally upregulated in gliomas, and its higher expression was associated with poor prognosis of the glioma patients; (2) Cellular experiments verified the nuclear localization and pro-invasion role of Pontin in glioma cells; (3) Preliminary analysis of the RNA-seq data revealed that, endogenous Pontin knockdown resulted in significant inhibition of the TGF-β signaling pathway and dysregulation of TβRII gene transcription and alternative splicing. According to these results, we propose the hypothesis that, Pontin participates in the regulation of TβRII gene transcription and alternative splicing, thereby activates TGF-β signaling and contributes to glioma invasion. In this project, we aim to adopt molecular, cellular and animal biology techniques, to explore the function of Pontin in invasion and other malignant behaviors of glioma, and to dissect the molecular mechanism of Pontin in regulating TβRII gene transcription and alternative splicing. Taken together, this project will identify the novel onco-protein Pontin in regulating glima invasion, and provides novel strategies and potential therapeutic targets for glioma treatment.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide.
通过将紫杉醇与细胞缀合改善抗胶质母细胞瘤活性和 BBB 通透性 — 穿透性 MMP — 2 — 可裂解肽
DOI:
10.1002/advs.202001960
发表时间:
2021-03
期刊:
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
影响因子:
--
作者:
[Hua D, Tang L, Wang W, Tang S, Yu L, Zhou X, Wang Q, Sun C, Shi C, Luo W, Jiang Z, Li H, Yu S]
通讯作者:
Yu S
DOI:
--
发表时间:
2022
期刊:
生命的化学
影响因子:
作者:
[安文哲, 李雪冰, 周雪霞]
通讯作者:
周雪霞
The miR-29 family members induce glioblastoma cell apoptosis by targeting cell division cycle 42 in a p53-dependent manner
miR-29家族成员通过p53依赖性方式靶向细胞分裂周期42诱导胶质母细胞瘤细胞凋亡
DOI:
10.1111/eci.13964
发表时间:
2023
期刊:
Eur J Clin Invest
影响因子:
--
作者:
[Shi C, Luo W, Sun C, Yu L, Zhou X, Hua D, Jiang Z, Wang Q, Yu S]
通讯作者:
Yu S
Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression
桉树 A 通过抑制 SRSF1 表达来纠正 MYO1B mRNA 的致癌剪接来抑制神经胶质瘤
DOI:
10.1016/j.ejphar.2020.173669
发表时间:
2021-01-05
期刊:
EUROPEAN JOURNAL OF PHARMACOLOGY
影响因子:
5
作者:
[Hua, Dan, Zhao, Qian, Yu, Shizhu]
通讯作者:
Yu, Shizhu
DOI:
10.1111/1759-7714.14536
发表时间:
2022-08
期刊:
Thoracic cancer
影响因子:
2.9
作者:
[]
通讯作者:
共 9 条
缺氧微环境下CLK1/SRSF1调控LDHA可变剪接促进胶质母细胞瘤糖酵解及恶性进展的机制研究
-
批准号:82172901
-
项目类别:面上项目
-
资助金额:54.7万元
-
批准年份:2021
-
负责人:周雪霞
-
依托单位:
剪接蛋白SRSF1在恶性胶质瘤发生发展中的作用及机制研究
-
批准号:81502166
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2015
-
负责人:周雪霞
-
依托单位:
国内基金
海外基金